Cannara Biotech (CNSX:LOVE – Get Free Report) Director Donald John Olds purchased 25,000 shares of the stock in a transaction on Tuesday, December 10th. The stock was bought at an average price of $0.78 per share, for a total transaction of $19,400.00.
Cannara Biotech Price Performance
About Cannara Biotech
Cannara Biotech Inc is a vertically integrated cannabis company building the largest indoor cannabis cultivation facility in Quebec, a modern and secure 625,000 square foot facility. Leveraging Quebec’s low electricity costs, Cannara will produce high-grade indoor cannabis, specializing in derivative products and brands.
Featured Articles
- Five stocks we like better than Cannara Biotech
- The How And Why of Investing in Oil Stocks
- WallStreetBets: How a Reddit Forum Shook Up Stock Market Dynamics
- What Are Some of the Best Large-Cap Stocks to Buy?
- Are 2024’s Top Insider Buys a Good Bet for 2025?
- Want to Profit on the Downtrend? Downtrends, Explained.
- 4 Social Media Stocks to Soar as TikTok’s Future Hangs in Balance
Receive News & Ratings for Cannara Biotech Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cannara Biotech and related companies with MarketBeat.com's FREE daily email newsletter.
